Literature DB >> 17458695

CYP1B1 and predisposition to breast cancer in Poland.

Joanna Matyjasik1, Cezary Cybulski, Bartlomiej Masojć, Anna Jakubowska, Pablo Serrano-Fernandez, Bohdan Górski, Tadeusz Debniak, Tomasz Huzarski, Tomasz Byrski, Jacek Gronwald, Elzbieta Złowocka, Steven Alexander Narod, Rodney Scott, Jan Lubinski.   

Abstract

BACKGROUND: The CYP1B1 gene is a polymorphic member of the P450 gene family and is considered to be a candidate gene for cancers of various types.
OBJECTIVE: We inquired whether four SNPs in the CYP1B1 gene, alone or in combination, might be associated with breast cancer risk in Poland.
METHODS: We genotyped 2017 cases of breast cancer and 876 controls, for four SNPs in the CYP1B1 gene. Genotype and haplotype frequencies were compared in cases and controls.
RESULTS: In combinations of the R48G, A119S and L432V SNPs, four of the eight CYP1B1 haplotypes were more common in controls than in cases and each of these appeared to have a significant protective effect. A large reduction in risk was observed for women who were homozygous for one of these four haplotypes (OR = 0.2; 95%; CI = 0.05-0.5; P = 0.001) compared to women who were homozygous for the most common haplotype. In contrast, women who were homozygous for the GTC haplotype were at increased risk (OR = 1.5; 95%; CI = 1.0-2.1; P = 0.03) compared to women with the most common haplotype.
CONCLUSIONS: The CYP1B1 gene appears to influence breast cancer susceptibility in Poland.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17458695     DOI: 10.1007/s10549-007-9500-4

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  5 in total

1.  Association between the CYP1B1 polymorphisms and risk of cancer: a meta-analysis.

Authors:  Jie-Ying Liu; Yu Yang; Zhi-Zhong Liu; Jian-Jun Xie; Ya-Ping Du; Wei Wang
Journal:  Mol Genet Genomics       Date:  2014-12-05       Impact factor: 3.291

2.  Clinical Significance of Gene Mutations and Polymorphic Variants and their Association with Prostate Cancer Risk in Polish Men.

Authors:  Marta Heise; Piotr Jarzemski; Dagmara Nowak; Aneta Bąk; Anna Junkiert-Czarnecka; Maria Pilarska-Deltow; Maciej Borysiak; Beata Pilarska; Olga Haus
Journal:  Cancer Control       Date:  2022 Jan-Dec       Impact factor: 2.339

3.  Genetic polymorphisms in the catechol estrogen metabolism pathway and breast cancer risk.

Authors:  Kerryn W Reding; Noel S Weiss; Chu Chen; Christopher I Li; Christopher S Carlson; Hui-Wen Wilkerson; Federico M Farin; Kenneth E Thummel; Janet R Daling; Kathleen E Malone
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-04-21       Impact factor: 4.254

4.  Evaluation of CYP17A1 and CYP1B1 polymorphisms in male breast cancer risk.

Authors:  Piera Rizzolo; Valentina Silvestri; Virginia Valentini; Veronica Zelli; Agostino Bucalo; Ines Zanna; Simonetta Bianchi; Maria Grazia Tibiletti; Antonio Russo; Liliana Varesco; Gianluca Tedaldi; Bernardo Bonanni; Jacopo Azzollini; Siranoush Manoukian; Anna Coppa; Giuseppe Giannini; Laura Cortesi; Alessandra Viel; Marco Montagna; Paolo Peterlongo; Paolo Radice; Domenico Palli; Laura Ottini
Journal:  Endocr Connect       Date:  2019-08       Impact factor: 3.335

5.  DNA testing for variants conferring low or moderate increase in the risk of cancer.

Authors:  Grzegorz Kurzawski; Janina Suchy; Cezary Cybulski; Joanna Matyjasik; Tadeusz Debniak; Bohdan Górski; Tomasz Huzarski; Anna Janicka; Jolanta Szymanska-Pasternak; Jan Lubinski
Journal:  Hered Cancer Clin Pract       Date:  2008-06-15       Impact factor: 2.857

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.